This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Events & Webinars
  • Podcasts
  • Resources
  • Learning Zone
  • Products
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer cross colorful
Bayer for ProfessionalsYour Resource Portal
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Patient Support Materials
    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2368, August 2024
    Xarelto® (rivaroxaban) Patient Support Materials
    Access useful, downloadable cardiovascular resources for patients
    Xarelto Prescribing Information
    PP-XAR-GB-3663, October 2024
    Patient Materials
    Useful, downloadable resources
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0072, April 2024
    Case Studies
    View more
    mCRPC Patient Case Study
    A Nuclear Medicine perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0575, June 2024
    mCRPC Patient Case Study
    An Oncologist Perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0574, June 2024
    nmCRPC Patient Case Study
    NUBEQA® (darolutamide) - An Oncologist Perspective
    NUBEQA Prescribing Information
    PP-NUB-GB-2031, January 2025
    nmCRPC Patient Case Study
    NUBEQA® (darolutamide) - A Urologist Perspective
    NUBEQA Prescribing Information
    PP-NUB-GB-2038, January 2025
    Women's Health Resources
    View more
    Patient case study: Anxious about hormones
    Discussion on counselling a patient anxious about hormones and wants a non-hormonal contraceptive option.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0020, February 2024
    Patient Case Study: The Tricky fit
    Discussion on a referral with intracervical blocks.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0021, February 2024
    Patient case study: The forgetful pill taker
    Discussion who wants to find a contraceptive method that will suit her busy student lifestyle.
    Kyleena® Prescribing Information
    PP-PF-WHC-IUS-GB-0022, February 2024
    Counselling patients
    Simple steps from INTRA to successfully counsel women about intrauterine contraception (IUC) in under 7 minutes.
    PP-PF-WHC-IUS-GB-0062, February 2024
    Cardiology Resources
    View more
    Xarelto® (rivaroxaban) Patient Support Materials
    Access useful, downloadable cardiovascular resources for patients
    Xarelto Prescribing Information
    PP-XAR-GB-3663, October 2024
    Oncology Resources
    View more
    Gathering consensus on mHSPC Treatment
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2230, March 2025
    mCRPC Patient Case Study
    A Nuclear Medicine perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0575, June 2024
    mCRPC Patient Case Study
    An Oncologist Perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0574, June 2024
    Xofigo®▼ (radium-223 dichloride) Resources
    Xofigo Prescribing Information
    PP-XOF-GB-0626, April 2025
    Ophthalmology Resources
    View more
    Real World Experience
    Practical insights into the experiences of clinicians implementing treatment with EYLEA® (aflibercept) 8 mg in the UK
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2790, March 2025
    HCP Resources
    Access useful, downloadable ophthalmology resources for HCPs
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2866, June 2025
    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2368, August 2024
    EYLEA® (aflibercept) Risk Minimisation Materials
    Visit to access Risk Minimisation Materials for EYLEA® (aflibercept)
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2647, December 2024